Widening the Therapeutic Window in the Management of Parkinson’s Disease


Expert neurologists discuss strategies to widen the therapeutic window of Parkinson’s disease and options available to treat dyskinesia, providing better control of Parkinson’s disease.

To watch the full video episode, follow this link.

1:12 Long-term challenges

4:00 Levodopa fluctuations

6:30 Therapeutic window

9:20 Amantadine DR/ER for PD

11:30 Dyskinesia treatment

18:10 Amantadine candidates

23:34 PK of amantadine

27:15 Early treatment

Related Videos
Ray Dorsey, MD
© 2024 MJH Life Sciences

All rights reserved.